, operates the business of manufacturing and distribution of dialysis and medical equipment, later in February 2018, NCLpurchased some shares from a shareholder, making it the major shareholder with 52.80% of
overview of performance. Unit : Million Baht For the three-months ended 31 March Items Increased (Decreased) 2019 2018 Amount Percentage 1 Revenue from steel tower manufacturing 226.94 177.01 49.93 28.21 2
. Unit : Million Baht For the three-months ended 31 March Items Increased (Decreased) 2018 2017 Amount Percentage 1 Revenue from steel tower manufacturing 177.01 249.73 (72.72) (29.12) 2 Revenue from sale
solution and other medical product manufacturing and trading business. Previously the company held 44% of all shares. Later in February 2018, the company acquired additional shares from one of the
% % 2020 % 2019 % % Revenue from sale 272.47 41.07% 389.02 71.31% -29.96% 600.81 60.91% 795.91 66.61% -24.51% Revenue from manufacturing and service 105.03 15.83% 147.41 27.02% -28.75% 216.52 21.95% 376.15
in quarter 3/2020. Revenue from manufacturing and service of 419.16 million baht as 227.84 million baht decreased or 35.21 percent when compared to the same period of previous year of 647 million
Baht 852.55 million, together with the decrease of regular transactions of Trading at the amount of Baht 411.37 million and the decrease of revenue from Manufacturing-Energy (PPP) at the amount of Baht
in financing activities amounting to 1,074 MTHB, consisting mainly of dividends paid to shareholders for 1,067 MTHB. Net cash flow from operating activities 3,960 MTHB Net cash flow used in investing
more interest received from short term investment on excess cash. 3. In 2019, the net cash flow used in financing activities amounting to 1,541 MTHB which was the dividends paid to shareholders. Net cash
10.97 million or 9.53% from the corresponding period of the previous year, mostly from Interest income (financing composition separation from revenue from sales) decreased Baht 22.47 million and profit